Insider Transactions in Q1 2023 at Evolent Health, Inc. (EVH)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 07
2023
|
Frank J Williams Director |
SELL
Open market or private sale
|
Direct |
116,311
-12.42%
|
$3,954,574
$34.62 P/Share
|
Mar 07
2023
|
Seth Blackley Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
95,055
-10.83%
|
$3,231,870
$34.62 P/Share
|
Mar 06
2023
|
Frank J Williams Director |
SELL
Open market or private sale
|
Direct |
90,356
-4.41%
|
$3,072,104
$34.71 P/Share
|
Mar 06
2023
|
Seth Blackley Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
73,928
-3.89%
|
$2,513,552
$34.71 P/Share
|
Mar 03
2023
|
Frank J Williams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
400,000
+28.04%
|
-
|
Mar 03
2023
|
Seth Blackley Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
360,000
+27.44%
|
-
|
Mar 02
2023
|
Steve Tutewohl Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,200
-2.45%
|
$112,000
$35.15 P/Share
|
Mar 02
2023
|
Jonathan Weinberg General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,330
-2.17%
|
$116,550
$35.15 P/Share
|
Mar 02
2023
|
John Paul Johnson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,020
-4.32%
|
$315,700
$35.15 P/Share
|
Mar 02
2023
|
Daniel Joseph Mc Carthy PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
4,687
-2.21%
|
$164,045
$35.15 P/Share
|
Mar 01
2023
|
Seth Blackley Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,470
-1.25%
|
$261,450
$35.26 P/Share
|
Mar 01
2023
|
Seth Blackley Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
59,002
+8.96%
|
-
|
Mar 01
2023
|
Steve Tutewohl Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,176
-1.64%
|
$76,160
$35.26 P/Share
|
Mar 01
2023
|
Steve Tutewohl Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,011
+11.36%
|
-
|
Mar 01
2023
|
Jonathan Weinberg General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,265
-1.46%
|
$79,275
$35.26 P/Share
|
Mar 01
2023
|
Jonathan Weinberg General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
12,758
+7.58%
|
-
|
Mar 01
2023
|
John Paul Johnson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,681
-1.73%
|
$128,835
$35.26 P/Share
|
Mar 01
2023
|
John Paul Johnson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,413
+8.76%
|
-
|
Mar 01
2023
|
Aammaad Shams Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
672
-1.27%
|
$23,520
$35.26 P/Share
|
Mar 01
2023
|
Aammaad Shams Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+23.23%
|
-
|
Mar 01
2023
|
Daniel Joseph Mc Carthy PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
2,457
-1.15%
|
$85,995
$35.26 P/Share
|
Mar 01
2023
|
Daniel Joseph Mc Carthy PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
27,557
+11.39%
|
-
|
Mar 01
2023
|
Frank J Williams Director |
SELL
Open market or private sale
|
Direct |
110,000
-7.65%
|
$3,740,000
$34.98 P/Share
|
Mar 01
2023
|
Frank J Williams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
110,000
+6.8%
|
$550,000
$5.36 P/Share
|
Feb 21
2023
|
Jonathan Weinberg General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,847
-2.62%
|
$107,716
$28.08 P/Share
|
Feb 21
2023
|
Jonathan Weinberg General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
11,550
+7.3%
|
-
|
Feb 21
2023
|
John Paul Johnson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,025
-9.43%
|
$560,700
$28.08 P/Share
|
Feb 21
2023
|
John Paul Johnson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
44,000
+17.17%
|
-
|
Feb 21
2023
|
Steve Tutewohl Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,774
-3.96%
|
$133,672
$28.08 P/Share
|
Feb 21
2023
|
Steve Tutewohl Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,300
+10.61%
|
-
|
Feb 21
2023
|
Daniel Joseph Mc Carthy PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
8,461
-4.33%
|
$236,908
$28.08 P/Share
|
Feb 21
2023
|
Daniel Joseph Mc Carthy PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+12.34%
|
-
|
Feb 21
2023
|
Seth Blackley Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
87,786
-13.97%
|
$2,458,008
$28.08 P/Share
|
Feb 21
2023
|
Seth Blackley Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
206,211
+24.71%
|
-
|
Feb 01
2023
|
Frank J Williams Director |
SELL
Open market or private sale
|
Direct |
110,000
-7.49%
|
$3,520,000
$32.41 P/Share
|
Feb 01
2023
|
Frank J Williams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
110,000
+13.0%
|
$330,000
$3.84 P/Share
|
Jan 03
2023
|
Frank J Williams Director |
SELL
Open market or private sale
|
Direct |
110,000
-7.51%
|
$2,970,000
$27.65 P/Share
|
Jan 03
2023
|
Frank J Williams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
110,000
+13.0%
|
$330,000
$3.84 P/Share
|